Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001292629 | SCV001481221 | uncertain significance | Exostoses, multiple, type 2 | 2019-10-12 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Invitae | RCV001292629 | SCV001532572 | likely benign | Exostoses, multiple, type 2 | 2023-02-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003416156 | SCV004115610 | uncertain significance | EXT2-related disorder | 2022-08-29 | criteria provided, single submitter | clinical testing | The EXT2 c.1685G>A variant is predicted to result in the amino acid substitution p.Arg562Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.080% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-44253925-G-A), which is likely too common for an undocumented disease-causing variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |